Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1462651

Cover Image

PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1462651

Weight Loss and Obesity Management Market Forecasts to 2030 - Global Analysis By Product Type, Age Group, Equipment, Service, Distribution Channel, End User and By Geography

PUBLISHED:
PAGES: 200+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4150
PDF (2-5 User License)
USD 5250
PDF & Excel (Site License)
USD 6350
PDF & Excel (Global Site License)
USD 7500

Add to Cart

According to Stratistics MRC, the Global Weight Loss and Obesity Management Market is accounted for $282.9 billion in 2023 and is expected to reach $554.9 billion by 2030 growing at a CAGR of 10.1% during the forecast period. Technologies and drugs that assist obese or overweight people in losing weight or maintaining their weight are included in the weight loss and obesity management market. Fundamentally, obesity is a long-term medical condition characterized by abnormal fat deposition and accumulation in the body. The Body Mass Index, or BMI, is used to compute it. Some of the methods used to address weight loss and obesity include medications, exercise, nutritional supplements, and weight reduction surgery.

According to a report published by Trust for America's Health, a health policy organization, in 2021, the nation's obesity crisis found that 19 states have obesity rates over 35 percent in U.S.

Market Dynamics:

Driver:

Increasing obesity rates

With a surge in sedentary lifestyles, unhealthy dietary habits, and environmental factors conducive to weight gain, the prevalence of obesity has reached alarming levels. As individuals become increasingly aware of the health risks associated with obesity, including cardiovascular diseases, diabetes, and certain types of cancer, there is a growing demand for effective weight management solutions. This demand fuels the development and adoption of various interventions, ranging from lifestyle modification programs to pharmaceuticals and surgical procedures.

Restraint:

High costs

The expenses associated with weight loss programs, including medications, surgery, counseling, and specialized diets, can pose a barrier to individuals seeking help, particularly those with lower incomes or inadequate health insurance coverage. The financial burden of these interventions often deters individuals from pursuing professional assistance or adhering to prescribed treatment plans. However, the lack of comprehensive insurance coverage for weight loss services further exacerbates the issue, leaving many individuals unable to afford essential treatments. As a result, disparities in access to care widen, perpetuating inequalities in health outcomes related to obesity.

Opportunity:

Technological advancements

Innovative technologies offer diverse solutions, ranging from wearable fitness trackers and mobile applications to advanced surgical techniques and pharmaceutical interventions. These advancements enable personalized and precise strategies for weight loss and obesity management, catering to individual needs and preferences. Digital health platforms provide real-time monitoring, data analysis, and behavior tracking, empowering individuals to make informed decisions about their health and lifestyle choices.

Threat:

Lack of effective long-term solutions

While numerous weight loss interventions exist, sustaining weight loss over the long term remains a significant challenge for many individuals. Fad diets, supplements and temporary lifestyle changes often yield initial results, but they frequently fail to provide lasting benefits. This lack of sustained efficacy undermines consumer confidence and hinders the growth of the market. Moreover, obesity is a complex condition with multifactorial causes, including genetic, environmental, and behavioral factors, making it difficult to develop universally effective treatments.

Covid-19 Impact:

Lockdowns, restrictions on movement, and social distancing measures led to disrupted routines, reduced physical activity, and increased sedentary behavior among populations worldwide. Stress, anxiety, and uncertainty further contributed to unhealthy eating habits and weight gain for many individuals. Conversely, some individuals used the pandemic as an opportunity to prioritize their health and focus on weight loss goals. Telehealth and virtual consultations surged in popularity, enabling remote access to healthcare professionals and weight management programs.

The fitness equipment segment is expected to be the largest during the forecast period

Fitness Equipment segment is expected to hold the largest share during the forecast period. With the rising awareness of the health risks associated with obesity, there's an increasing demand for convenient and effective ways to manage weight. Fitness equipment such as treadmills, stationary bikes, elliptical trainers, and weight lifting machines provide users with versatile options for engaging in physical activity tailored to their preferences and abilities. This accessibility and versatility of fitness equipment empower individuals to take proactive steps towards achieving their weight loss goals, thereby driving growth within the market.

The slimming centers segment is expected to have the highest CAGR during the forecast period

Slimming Centers segment is positioned to witness the profitable growth throughout the overcast period as it offers personalized, comprehensive programs tailored to individual needs, including diet plans, exercise routines, and often, medical supervision. With rising awareness about health and fitness, coupled with the increasing prevalence of obesity, more people are turning to slimming centers for professional guidance and support in achieving their weight loss goals.

Region with largest share:

Asia Pacific region dominated the largest share of the market throughout the estimated period. As awareness grows regarding the adverse effects of obesity on health, individuals are seeking tailored solutions that cater to their specific needs and circumstances. Personalized healthcare approaches, such as genetic testing, customized diet plans, and targeted exercise regimens, are gaining traction as they offer more effective and sustainable results compared to generic treatments. Moreover, wearable fitness devices and mobile health apps, empower individuals to monitor their progress and make informed decisions about their health journey.

Region with highest CAGR:

Europe region is poised to hold lucrative growth over the projection period. As individuals in these regions attain higher levels of income, they tend to prioritize health and wellness, including efforts to manage weight and combat obesity. This burgeoning demand has had a notable impact on the European market for weight loss and obesity management products and services. European companies in this sector are capitalizing on the opportunity by expanding their operations and distribution networks to cater to the growing demand from developing countries. As a result, these elements are boosting the regional growth.

Key players in the market

Some of the key players in Weight Loss and Obesity Management market include Allergan Plc, Allurion Technologies Inc, Amgen Inc, Apollo Endosurgery, Inc, Aspire Bariatrics, Eisai Co., Ltd, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Herbalife International of America, Inc, Medtronic, Novo Nordisk A/S, ReShape Lifesciences, Inc, Rhythm Pharmaceuticals, Inc and Takeda Pharmaceutical Company Limited.

Key Developments:

In March 2023, PRISTYN CARE, a healthcare service provider, announced that it has entered into a strategic partnership with Allurion, a company developing a medical device for weight loss, in order to offer a weight-loss and obesity care platform.

In December 2022, Amgen Inc., announced new Phase 1 data from AMG 133, a novel bispecific glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist and glucagon-like peptide-1 (GLP-1) receptor agonist molecule. This first-in-human study was designed to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic effects of AMG 133 in people with obesity and without diabetes.

Product Types Covered:

  • Drugs
  • Devices
  • Other Product Types

Age Groups Covered:

  • Under 18 Years
  • 18 To 35 Years
  • 35 To 50 Years
  • Above 50 Years

Equipments Covered:

  • Cardiovascular Training Equipment
  • Fitness Equipment
  • Strength Training Equipment
  • Surgical Equipment
  • Other Equipments

Services Covered:

  • Consulting Services
  • Slimming Centers
  • Fitness Centers
  • Online Weight Loss Programs
  • Other Services

Distribution Channels Covered:

  • Retail Sales
  • Pharmaceutical Stores
  • Hypermarket/ Supermarket
  • Other Distribution Channels

End Users Covered:

  • Hospitals
  • Ambulatory Surgery Centres
  • Weight Loss Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Product Code: SMRC25702

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Weight Loss and Obesity Management Market, By Product Type

  • 5.1 Introduction
  • 5.2 Drugs
    • 5.2.1 Combination Drugs
    • 5.2.2 Serotonin Receptor Agonists
    • 5.2.3 Lipase Inhibitors
    • 5.2.4 GLP-1 Receptor Agonists
    • 5.2.5 Centrally Acting Drugs
    • 5.2.6 Other Drugs
  • 5.3 Devices
    • 5.3.1 Gastric Electrical Stimulation Systems
    • 5.3.2 Gastric Emptying Systems
    • 5.3.3 Gastric Balloon Systems
    • 5.3.4 Gastric Bands
    • 5.3.5 Bariatric Stapling Devices
    • 5.3.6 Other Devices
  • 5.4 Other Product Types

6 Global Weight Loss and Obesity Management Market, By Age Group

  • 6.1 Introduction
  • 6.2 Under 18 Years
  • 6.3 18 To 35 Years
  • 6.4 35 To 50 Years
  • 6.5 Above 50 Years

7 Global Weight Loss and Obesity Management Market, By Equipment

  • 7.1 Introduction
  • 7.2 Cardiovascular Training Equipment
  • 7.3 Fitness Equipment
  • 7.4 Strength Training Equipment
  • 7.5 Surgical Equipment
  • 7.6 Other Equipments

8 Global Weight Loss and Obesity Management Market, By Service

  • 8.1 Introduction
  • 8.2 Consulting Services
  • 8.3 Slimming Centers
  • 8.4 Fitness Centers
  • 8.5 Online Weight Loss Programs
  • 8.6 Other Services

9 Global Weight Loss and Obesity Management Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Retail Sales
  • 9.3 Pharmaceutical Stores
  • 9.4 Hypermarket/ Supermarket
  • 9.5 Other Distribution Channels

10 Global Weight Loss and Obesity Management Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Ambulatory Surgery Centres
  • 10.4 Weight Loss Clinics
  • 10.5 Other End Users

11 Global Weight Loss and Obesity Management Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Allergan Plc
  • 13.2 Allurion Technologies Inc
  • 13.3 Amgen Inc
  • 13.4 Apollo Endosurgery, Inc
  • 13.5 Aspire Bariatrics
  • 13.6 Eisai Co., Ltd
  • 13.7 F. Hoffmann-La Roche Ltd
  • 13.8 GlaxoSmithKline plc
  • 13.9 Herbalife International of America, Inc
  • 13.10 Medtronic
  • 13.11 Novo Nordisk A/S
  • 13.12 ReShape Lifesciences, Inc
  • 13.13 Rhythm Pharmaceuticals, Inc
  • 13.14 Takeda Pharmaceutical Company Limited
Product Code: SMRC25702

List of Tables

  • Table 1 Global Weight Loss and Obesity Management Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Weight Loss and Obesity Management Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Weight Loss and Obesity Management Market Outlook, By Drugs (2021-2030) ($MN)
  • Table 4 Global Weight Loss and Obesity Management Market Outlook, By Combination Drugs (2021-2030) ($MN)
  • Table 5 Global Weight Loss and Obesity Management Market Outlook, By Serotonin Receptor Agonists (2021-2030) ($MN)
  • Table 6 Global Weight Loss and Obesity Management Market Outlook, By Lipase Inhibitors (2021-2030) ($MN)
  • Table 7 Global Weight Loss and Obesity Management Market Outlook, By GLP-1 Receptor Agonists (2021-2030) ($MN)
  • Table 8 Global Weight Loss and Obesity Management Market Outlook, By Centrally Acting Drugs (2021-2030) ($MN)
  • Table 9 Global Weight Loss and Obesity Management Market Outlook, By Other Drugs (2021-2030) ($MN)
  • Table 10 Global Weight Loss and Obesity Management Market Outlook, By Devices (2021-2030) ($MN)
  • Table 11 Global Weight Loss and Obesity Management Market Outlook, By Gastric Electrical Stimulation Systems (2021-2030) ($MN)
  • Table 12 Global Weight Loss and Obesity Management Market Outlook, By Gastric Emptying Systems (2021-2030) ($MN)
  • Table 13 Global Weight Loss and Obesity Management Market Outlook, By Gastric Balloon Systems (2021-2030) ($MN)
  • Table 14 Global Weight Loss and Obesity Management Market Outlook, By Gastric Bands (2021-2030) ($MN)
  • Table 15 Global Weight Loss and Obesity Management Market Outlook, By Bariatric Stapling Devices (2021-2030) ($MN)
  • Table 16 Global Weight Loss and Obesity Management Market Outlook, By Other Devices (2021-2030) ($MN)
  • Table 17 Global Weight Loss and Obesity Management Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 18 Global Weight Loss and Obesity Management Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 19 Global Weight Loss and Obesity Management Market Outlook, By Under 18 Years (2021-2030) ($MN)
  • Table 20 Global Weight Loss and Obesity Management Market Outlook, By 18 To 35 Years (2021-2030) ($MN)
  • Table 21 Global Weight Loss and Obesity Management Market Outlook, By 35 To 50 Years (2021-2030) ($MN)
  • Table 22 Global Weight Loss and Obesity Management Market Outlook, By Above 50 Years (2021-2030) ($MN)
  • Table 23 Global Weight Loss and Obesity Management Market Outlook, By Equipment (2021-2030) ($MN)
  • Table 24 Global Weight Loss and Obesity Management Market Outlook, By Cardiovascular Training Equipment (2021-2030) ($MN)
  • Table 25 Global Weight Loss and Obesity Management Market Outlook, By Fitness Equipment (2021-2030) ($MN)
  • Table 26 Global Weight Loss and Obesity Management Market Outlook, By Strength Training Equipment (2021-2030) ($MN)
  • Table 27 Global Weight Loss and Obesity Management Market Outlook, By Surgical Equipment (2021-2030) ($MN)
  • Table 28 Global Weight Loss and Obesity Management Market Outlook, By Other Equipments (2021-2030) ($MN)
  • Table 29 Global Weight Loss and Obesity Management Market Outlook, By Service (2021-2030) ($MN)
  • Table 30 Global Weight Loss and Obesity Management Market Outlook, By Consulting Services (2021-2030) ($MN)
  • Table 31 Global Weight Loss and Obesity Management Market Outlook, By Slimming Centers (2021-2030) ($MN)
  • Table 32 Global Weight Loss and Obesity Management Market Outlook, By Fitness Centers (2021-2030) ($MN)
  • Table 33 Global Weight Loss and Obesity Management Market Outlook, By Online Weight Loss Programs (2021-2030) ($MN)
  • Table 34 Global Weight Loss and Obesity Management Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 35 Global Weight Loss and Obesity Management Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 36 Global Weight Loss and Obesity Management Market Outlook, By Retail Sales (2021-2030) ($MN)
  • Table 37 Global Weight Loss and Obesity Management Market Outlook, By Pharmaceutical Stores (2021-2030) ($MN)
  • Table 38 Global Weight Loss and Obesity Management Market Outlook, By Hypermarket/ Supermarket (2021-2030) ($MN)
  • Table 39 Global Weight Loss and Obesity Management Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 40 Global Weight Loss and Obesity Management Market Outlook, By End User (2021-2030) ($MN)
  • Table 41 Global Weight Loss and Obesity Management Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 42 Global Weight Loss and Obesity Management Market Outlook, By Ambulatory Surgery Centres (2021-2030) ($MN)
  • Table 43 Global Weight Loss and Obesity Management Market Outlook, By Weight Loss Clinics (2021-2030) ($MN)
  • Table 44 Global Weight Loss and Obesity Management Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!